■为了评估肌筋膜释放(MFR)技术对紧张型头痛(TTH)患者的头痛强度和相关残疾的有效性,颈源性头痛(CGH),或者偏头痛.
■系统评价和荟萃分析。
■在2023年9月15日搜索了八个数据库,包括PubMed,Scopus,WebofScience,CINAHL,科克伦图书馆,Embase,CNKI,和万方数据库。使用Cochrane偏差风险2(RoB2)工具评估偏差风险。
■汇总结果显示,MFR干预可显着降低疼痛强度[SMD=-2.01,95%CI(-2.98,-1.03),I2=90%,P<0.001]并改善残疾[SMD=-1.3,95%CI(-1.82,-0.79),I2=74%,P<0.001]。根据头痛类型进行的亚组分析显示,CGH的疼痛强度显着降低[SMD=-2.01,95%CI(-2.73,-1.29),I2=63%,P<0.001],TTH[SMD=-0.86,95%CI(-1.52,-0.20),I2=50%,P=0.01和偏头痛[SMD=-6.52,95%CI(-8.15,-4.89),P<0.001]和残疾的CGH[SMD=-1.45,95%CI(-2.07,-0.83),I2=0%,P<0.001;TTH[SMD=-0.98,95%CI(-1.32,-0.65),I2=0%,P<0.001,但非偏头痛[SMD=-2.44,95%CI(-6.04,1.16),I2=97%,P=0.18]。
■荟萃分析结果表明,MFR干预可以显着减轻TTH和CGH的疼痛和残疾。对于偏头痛,然而,结果不一致,TTH和CGH仅有中等质量的残疾改善证据。相比之下,其他证据的质量较低或非常低。
UNASSIGNED: To assess the effectiveness of myofascial release (MFR) techniques on the intensity of headache pain and associated disability in patients with tension-type headache (TTH), cervicogenic headache (CGH), or migraine.
UNASSIGNED: A systematic review and meta-analysis.
UNASSIGNED: Eight databases were searched on September 15, 2023, including PubMed, Scopus, Web of Science, CINAHL, Cochrane Library, Embase, CNKI, and Wanfang Database. The risk of bias was evaluated utilizing the Cochrane Risk of Bias 2 (RoB 2) tool.
UNASSIGNED: Pooled results showed that MFR intervention significantly reduces pain intensity [SMD = -2.01, 95% CI (-2.98, -1.03), I2 = 90%, P < 0.001] and improves disability [SMD = -1.3, 95% CI (-1.82, -0.79), I2 = 74%, P < 0.001]. Subgroup analysis based on the type of headache revealed significant reductions in pain intensity for CGH [SMD = -2.01, 95% CI (-2.73, -1.29), I2 = 63%, P < 0.001], TTH [SMD = -0.86, 95% CI (-1.52, -0.20), I2 = 50%, P=0.01] and migraine [SMD = -6.52, 95% CI (-8.15, -4.89), P < 0.001] and in disability for CGH [SMD = -1.45, 95% CI (-2.07, -0.83), I2 = 0%, P < 0.001]; TTH [SMD = -0.98, 95% CI (-1.32, -0.65), I2 = 0%, P < 0.001] but not migraine [SMD = -2.44, 95% CI (-6.04, 1.16), I2 = 97%, P=0.18].
UNASSIGNED: The meta-analysis results indicate that MFR intervention can significantly alleviate pain and disability in TTH and CGH. For migraine, however, the results were inconsistent, and there was only moderate quality evidence of disability improvement for TTH and CGH. In contrast, the quality of other evidence was low or very low.